# Augmenting Cerebral Blood Flow to Preserve the Penumbra Trial

Study · id `cardio:ct-nct04014621` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04014621](<https://clinicaltrials.gov/study/NCT04014621>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04014621

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT04014621. Randomized; quadruple masking; primary purpose treatment. Start 2019-10-20 (actual); primary completion 2021-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT04014621, source copy `cardio:ctgov-nct04014621-2019-10-30`, retrieved 2026-10-26)
- Started: 2019-10-20 (actual) (ClinicalTrials.gov record NCT04014621, source copy `cardio:ctgov-nct04014621-2019-10-30`, retrieved 2026-10-26)
- Primary completion: 2021-01 (anticipated) (ClinicalTrials.gov record NCT04014621, source copy `cardio:ctgov-nct04014621-2019-10-30`, retrieved 2026-10-26)
- Completion: 2021-04 (anticipated) (ClinicalTrials.gov record NCT04014621, source copy `cardio:ctgov-nct04014621-2019-10-30`, retrieved 2026-10-26)
- Countries: Georgia (ClinicalTrials.gov record NCT04014621, source copy `cardio:ctgov-nct04014621-2019-10-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04014621-2019-10-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Augmenting Cerebral Blood Flow to Preserve the Penumbra Trial
- Acronym: ImpACT-P
- Condition: Ischemic Stroke
- Intervention (Device): SPG stimulation
- Lead sponsor: BrainsGate
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: bd163e87c9fbb9fec9d1e0640d78af0421870a1a335decf92cf2a5063b8bfe6e
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
